NDC product
Abiraterone Acetate
NDC 0093-1125 · Teva Pharmaceuticals USA, Inc.
Key facts
| Product NDC | 0093-1125 |
|---|---|
| Proprietary name | Abiraterone Acetate |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Marketing category | ANDA |
| Application number | ANDA208432 |
| Marketing start | Nov 21, 2018 |
| Marketing end | Mar 31, 2021 |
| Listing certified through | Mar 31, 2021 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: